IL22 and pneumonia: When the interleukin-25-induced group 2 innate lymphoid cells (ILC2) and interleukin-22 (IL-22)-producing group 3 innate lymphoid cells (ILC3) migrate to the lung, the host resistance to pneumonia and other inflammatory infections could be promoted [59,60,61,62].